Brownstone Journal

Brownstone Journal

By Brownstone InstituteNewsNews Commentary
Download on the App Store

Brownstone Journal episodes

  • The Herd Immunity Fallacy What Is Herd Immunity? History of Herd Immunity Outlook for Achieving Herd Immunity Challenges in Reaching Herd Immunity The Myth of Herd Immunity for Covid-19 mRNA "Vaccines" Were Not Designed to Achieve Herd Immunity Conclusion
    By Jennifer Smith at Brownstone dot org.
    During the pandemic and in the wake of recent measles outbreaks, many have pointed to the concept of "herd immunity" as a key reason to get vaccinated. This cartoon highlights how herd immunity is sometimes oversimplified or misapplied in discussions about vaccination.

    When you think of a herd, you probably think of cows, wildebeest, or buffalo. In the animal world, there is safety in numbers – more pairs of eyes to look out for predators, for example.
    As humans, we don't generally have to worry about predators, but we can gain the protection of the herd in other ways.
    Herd immunity — also called population or community immunity — means that enough people in a group or area have immunity to a germ (for instance, a virus) that it no longer spreads easily. That includes people who haven't caught the disease, people who had the illness and recovered, and people who got a vaccine.
    Herd immunity didn't start as a vaccination concept—it came from livestock science in the 1800s.
    The term herd immunity was first used in 1894 by Daniel Elmer Salmon, Chief of the Bureau of Animal Industry (BIA), to describe the health and disease resistance of well-fed hog populations. The use of the phrase expanded in 1916 when BIA veterinary scientists used the term to describe immunity in cattle following infection with Brucellosis also known as "contagious abortion"—epidemics of spontaneous miscarriage—in cattle and sheep.
    In 1923, British bacteriologists began using the concept in experiments involving epidemics in mice, as part of efforts to better understand patterns of disease transmission in human populations. Unless there was a steady influx of susceptible mice (this is important to remember), the rising prevalence of immune individuals would end an epidemic. In a 1923 article in the Journal of Hygiene, Topley and G. S. Wilson described this phenomenon as "herd immunity."
    The idea moved into medicine and by the late 1920s, the concept had gained broader traction—particularly among British scientists—who used it to describe the accumulation of population-level immunity to diseases such as diphtheria, scarlet fever, and influenza. In 1922, Topley suggested a parallel between outbreaks in mice and children:
    "Such a likeness would seem to exist in the case of epidemic diseases affecting children of school age." He also wondered whether measures already "in vogue in dealing with epidemics among live-stock, where methods of segregation are so much more easily enforced than among human populations," might inform decisions about school closings amid epidemics.
    In a 1924 article in the Lancet, Dudley applied "herd immunity" to humans. In a 1929 article, "Human Adaptation to the Parasitic Environment," he wrote,
    "I will now consider the community, or the herd…Nations may be divided into urban or rural herds. Or we can contrast the shoregoing herd with the sailor herd, or herds dwelling in hospitals can be compared with those who live in mental hospitals."
    The concept of "herd immunity" became a fixture of epidemiology by the 1930s but the early researchers never settled on a clear definition.
    Herd immunity took on fresh prominence in the 1950s and 1960s as new vaccines raised crucial questions for public health policy. The idea shifted from simply describing natural immunity to actively achieving population protection through vaccination. Mass vaccination, discussions of disease eradication, and cost–benefit analyses of vaccination subsequently prompted more widespread use of the term "herd immunity."
    Herd immunity often results from a combination of people getting vaccinated and people getting infected with the microorganism (natural immunity). Both natural and vaccine immunity cause your body to make antibodies and immune cells that recognize a specific pathogen. Your body can then fight the pathogen off more easily the next time it sees it. It usually takes a large percentage of people with immunity to ach...
    17 min
  • Does the Flu Vaccine Prevent Death?
    By Eyal Shahar at Brownstone dot org.
    THE LANCET Regional Health — Europe
    Dear Editor,
    My letter is concerned with a topic of utmost importance: The effect of the flu vaccine on flu-related death. That's the ultimate endpoint of interest for vaccine effectiveness (VE) research, yet it is not captured in most studies that employ the test-negative design.
    Faksova et al. (January 2026) reported in your journal results from a large cohort study of the flu vaccine in 2024–2025 in elderly residents (age≥65) of three Nordic countries. The estimated VE against flu-related death was 63%, which corresponds to a risk ratio (RR) of 0.37. How robust is the result? What does sensitivity analysis show?
    The authors relied on a matched design to avoid confounding bias, a major threat in observational research. Unvaccinated members of the cohort were matched to the vaccinated (one-to-one matching) on several variables, including key comorbidities.

    Sweden was not included in the mortality analysis (small numbers), and the mortality graphs were displayed by country (Denmark, Finland). I will examine the data from Denmark, a matched cohort of over one million people.
    Graphs of cumulative mortality by vaccination status were displayed as of 14 days after a matched index date. For a vaccinated person, the index date was the vaccination date; for their unvaccinated counterpart, that matched date was just a random date on the calendar. I will return to this point later when we discuss their health status.

    Based on a total of 180 flu-related deaths, the risk ratio in Denmark was 0.37 (63% effectiveness). The denominators, person-years, were similar, so a simple ratio of the number of deaths gives almost the same result (48/132 = 0.36).
    The authors were aware of the healthy vaccinee effect, a type of confounding bias, and they examined several outcomes for which no effect of vaccination is expected. These are called "negative control outcomes." All-cause death was one such outcome because flu mortality was a tiny fraction of all-cause mortality (<2%), and we do not expect an effect of the flu vaccine on death from other causes. The results for this endpoint — graphs and estimates — were buried in a long supplementary appendix and were stated in one sentence in the main manuscript in a subsection titled negative control outcomes.

    Evidently, matching failed to remove the healthy vaccinee bias. The mortality graphs diverge, and quantitative analysis resulted in a "risk ratio" of 0.54 (pseudo-effectiveness of 46%). Again, since the denominators were similar, a simple ratio of the number of deaths gives almost the same result whether we divide the number of all-cause deaths (3,871/7,329 = 0.53) or subtract the small number of flu-related deaths (3,823/7,197 = 0.53). We have evidence that despite matching, the vaccinated were healthier than the unvaccinated, so the estimated risk ratio of flu-related death (0.37) is severely biased. In the Discussion, the authors try to downplay the implication.

    The degree of confounding for flu-related mortality is very clear — it is strong — and correcting the overestimated VE is not simple. The authors "caution against the use of these negative control outcomes VE estimates for direct calibration of influenza VE results." I would caution against using the phrase "direct calibration" for "removing bias." I would also caution against presenting a severely biased estimate against flu-related death without any attempt to get closer to the truth.
    According to one correction method, we divide the two biased risk ratios, RR (flu death)/RR (non-flu death) = 0.37/0.54 = 0.69, which is equivalent to multiplying the former (0.37) by the inverse of the latter (1/0.54 = 1.85). The origin of the method and its foundation are explained elsewhere. (The E-values, which were displayed in Table S12, are related to the topic. However, the authors did not acknowledge that the E-value for all-cause mortality is not "implied bias" but act...
    11 min
  • America's Drug Shortage Is a National Security Crisis A High-Tech Medical System Built on a Surprisingly Fragile Foundation The Economics of Cheap Medicine When America Almost Ran Out of IV Fluid This Is a National Security Issue We Need to Stop Buying Me
    By Joseph Varon at Brownstone dot org.
    There is a phrase that no physician wants to hear when walking into an intensive care unit: "Doctor, we don't have it." I have heard variations of that phrase more times than I care to remember. Sometimes it is an antibiotic. Sometimes it is an intravenous medication that we use routinely. Sometimes pharmacy is conserving a drug because supplies are running dangerously low. In perhaps one of the most absurd examples of modern American medicine, sometimes the scarce commodity is not an exotic monoclonal antibody, an experimental cancer therapy, or a complicated biologic agent. It is a simple intravenous fluid.
    Think about what that means. We practice medicine in a country capable of replacing heart valves through catheters, sequencing a human genome, performing robotic surgery, supporting failing lungs with extracorporeal membrane oxygenation, and developing entirely new classes of medications within a few years. Yet I can walk into an American intensive care unit caring for critically ill patients and discover that a basic medicine or fluid I have used for decades is unavailable.
    The nurses know the drill, and the pharmacists know it even better. A message comes from pharmacy telling us to conserve a medication, use a different concentration, substitute another antibiotic, change the infusion, or save the remaining bags for patients who absolutely need them. Suddenly, clinical decisions that should be based entirely upon physiology, microbiology, pharmacology, and the needs of the patient acquire another participant at the bedside: the supply chain. What was once perceived as an occasional inconvenience has become something much more serious. It is a warning.
    As of June 2026, the American Society of Health-System Pharmacists reported 227 active drug shortages in the United States, and nearly half of the new shortages reported during 2026 involved products available from only a single manufacturer.[1] Current shortage lists contain products whose names would be utterly unremarkable to anyone who has practiced hospital medicine: dextrose injections (water with sugar), sodium chloride products, amiodarone, midazolam, morphine, anti-infective agents, and numerous injectable medications that constitute the ordinary machinery of modern inpatient care.[1] These are not luxury items or niche therapeutics. They are the plumbing of medicine.
    Drug shortages are frequently discussed as isolated events. A factory experiences a quality problem, a production line shuts down, a raw material becomes scarce, demand unexpectedly increases, or a hurricane damages a manufacturing facility. Each shortage receives its own explanation, and eventually many of them resolve. Looking at these events individually, however, misses the much larger problem: the American pharmaceutical supply chain has been optimized for efficiency, low prices, and lean inventories, but it has not always been optimized for resilience.
    Over several decades, pharmaceutical manufacturing steadily migrated outside the United States. According to the FDA, more than half of pharmaceuticals distributed in America are manufactured overseas. As of 2025, approximately 69 percent of generic drug products were manufactured outside the United States. Even more striking, only about 11 percent of active pharmaceutical ingredient manufacturers were located in the United States, compared with approximately 22 percent in China and 44 percent in India.[2]
    This does not mean that Chinese or Indian manufacturers are inherently problematic. Many produce high-quality medicines that American patients depend upon every day, and a resilient pharmaceutical system should unquestionably include global suppliers. The problem is concentration. When the production of an essential drug, its active ingredient, or a critical chemical precursor becomes concentrated among only a handful of manufacturers or geographic regions, economic efficiency can quickly become a stra...
    27 min
  • Game Theory and the Push to Go Along Cooperative Game Theory The Prisoners' Dilemma: One-Time Choice to Collaborate or Defect Tit for Tat: Repetitive Choice to Collaborate or Defect Forced Game Theory Unequal Participants: Repetitive Collaborate or Defect
    By Brownstone Institute at Brownstone dot org.
    [Below is an excerpt from the excellent new book, Kill Switch: The History of How Viruses Shaped Humanity and Led to COVID-19, by Richard Burt. We highly recommend it. This portion of Chapter 16 provides an unforgettable explanation of how and why Covid dissidents were so few and far between within academia and industry. Game theory provides the answer. The chapter ends with a robust critique of the Bayh-Dole Act.]
    World War II ended when America dropped the atomic bombs named "Little Boy" and "Fat Man" on Hiroshima and Nagasaki. Hundreds of thousands of Japanese died in an instant and of radiation poisoning over the subsequent years. Several American politicians, military brass, and university academics advocated for preemptive war against Russia to prevent it from acquiring nuclear bombs. Francis Matthews, Secretary of the Navy, advocated becoming "aggressors for peace." The mathematician John von Neuman, who was a pioneer in game theory, remarked: "If you say bomb them tomorrow, I say why not bomb them today?"
    Once Russia detonated its own nuclear bomb in 1949, America's nuclear monopoly ended. In its place, a nuclear arms race jumped into the stratosphere. Nuclear weapons forever changed warfare in unpredictable ways. Because unorthodox thinking was needed, the US military funded an outside non-military corporation called RAND, an abbreviation for research and development.
    The RAND Corporation had carte blanche to hire whomever they wanted, to study whatever they wanted, to be independent of the military, and to go outside of the usual military thinking no matter how bizarre. The military needed options. RAND employed individuals
    from various fields, including mathematicians who studied game theories on how people settle conflicts. Game theory strives to understand how people solve conflicts to their best interest in different situations. Let us look at some of these situations.
    Developed in 1950 by RAND mathematicians Merrill Flood and Melvin Dresher, the theoretical game known as the prisoners' dilemma involves two equal participants who are given a one-time choice to collaborate or defect. In this scenario, the two prisoners have been arrested for a crime and have been kept in solitary confinement with no means of communication. Each prisoner is then interviewed by the authorities in separate rooms regarding who is guilty for the offense. Here are the rules:
    If neither prisoner says who did the crime, they both spend one year in jail.
    If only one of the prisoners says the other did the crime, the snitch goes free and the other spends four years in jail.
    If both prisoners say the other person did the crime, they both spend two years in jail.
    In the prisoners' dilemma, when both people collaborate to keep their mouths shut, they receive a far shorter sentence than if both attempted to defect (i.e., snitch on each other). However, most pairs defect, insofar as if the other person snitches and they do not, the one prisoner will go free, while the other will spend four years (i.e., twice as much time) in prison.
    According to game theory, the prisoners' dilemma reveals that people determine their course of action compared to the other party,
    not on the overall good for both. As the expression goes: "People want to see you do well but not better than them."
    An iterative (repetitive) version of the prisoners' dilemma was designed by political scientist Robert Axelrod. He called it "tit for tat." The rules are the same as for prisoners' dilemma, except that (1) you get a positive reward of money (or points) depending on whether you collaborate or defect; and (2) you will have to choose to collaborate or defect multiple times against the same opponent. You must consider what your counterpart will do in the next round based on your prior response. The goal is to win as much money (or points) as possible. Here is an example:
    If both individuals collaborate, both get twenty dollars.
    ...
    26 min
  • Four Forms of Numericide Numericide Number One: Blood Pressure at 120/80 Numericide's Number Two: Low-Density Lipoprotein, or LDL, under 100 mg/dL Numericide's Number Three: HbA1C (Hemoglobin A1C ) of 5.6 or Lower Numericide's Number Four: BMI under 25
    By Alan Cassels at Brownstone dot org.
    A recent article in the New York Times on the increasing rates of heart disease in young women (Why Are More Young Women Developing Heart Disease?) was amusingly frivolous and about as fact-free as an article about health advice can be.
    The key thrust of the article is that any woman who wants to preserve and improve her health should become informed of her "numbers." Which is to say, she should know her blood pressure, cholesterol, BMI, and hemoglobin A1C (a measure of average blood glucose levels) which are claimed to be "important for assessing risk."
    The Times quotes Dr Priya Freaney, director of the Women's Heart Care program at Northwestern Medicine: "Knowing your numbers is your most powerful tool," [she said] "And it's never too early to start."
    What numbers are we talking about? Well, apparently doctors recommend "all adults strive for these levels:"
    BP (Blood Pressure) under 120 mm Hg / 80 mm Hg
    LDL (Low-density lipoprotein) under 100 mg/dL
    HbA1C (Hemoglobin A1C ) of 5.6 or lower
    BMI (Body-mass index) under 25
    Now the four Horsemen of the Apocalypse, blood pressure, blood sugar, cholesterol, and BMI, threatening to strike you down in your healthy middle age unless you submit to the testing, treating (ie: medications and lifestyle changes), and a retesting paradigm which can lead many to become obsessed by the numbers.
    By the way, these four measures have one thing in common: They are typically treated with a prescribing pen that has been carefully guided in your doctor's expert hands by the helpful people in the pharmaceutical industry. Just saying…
    Let's approach these four with a bit of basic epidemiology, examining the wisdom of telling people of "average risk" to aim for these targets. Obviously, people with pre-existing conditions or those with inherently much higher or multiple risks (such as levels that are in the red flashing light category) involve a different calculus.
    But for the sake of evaluating the drive to push people toward these health targets, what do the highest quality studies ultimately say about the value in chasing these numeric targets in healthy people?
    I will always remember that old quip from an aging physician: "High blood pressure is better than no blood pressure at all." But the question one should ask is this: If you lower your blood pressure does it lead to a reduction in your chance of a cardiovascular event or dying?
    First off, despite what many guidelines and health care providers say about knowing your numbers, what they should have said was know your cardiovascular risk numbers (your percentage chance of having a heart attack or stroke over the next 10-30 years) not your numbers of cholesterol, blood pressure, or glucose numbers. Those are what we call 'surrogate markers' and the only reason to lower these numbers is to possibly reduce your risk of heart attacks and stroke. It's not that these surrogate numbers are useless — rather they are the wrong numbers to worry about. Their only use is to help us give a more accurate ballpark assessment of your cardiovascular risk.
    For starters, the target of 120 is not an evidence-based but an "expert-recommended" target, and in case you wondered, having a blood pressure of 130/80 or 140/90 is not the death sentence that your doctor might warn you about. Your blood pressure often jumps all over the map and how and when you measure it can significantly impact that number. It climbs as we get older, naturally. Like grey hair and wrinkles. Chasing this number is one of the biggest uses of a doctor's time and causes considerable (and frequently unnecessary) worry in patients.
    Me? I wish our doctors would have spent time learning more about evidence appraisal and how to properly do shared decision-making with their patients because the decision around the treatment of surrogate numbers is very dependent on a person's values and preferences. Cholesterol or blood pressure "management" makes a ton of money...
    17 min
  • WHO's High-Price Pandemic Plan
    By David Bell at Brownstone dot org.
    The recent release of Anthony Fauci's diaries, followed by his refusal to answer questions in an appearance before a US Senate committee by invoking the Fifth Amendment protection against self-incrimination 111 times, highlighted a stark divide in how the Covid pandemic was handled by public health authorities. This is as true of Australia as of the US.
    Repeatedly, against certainty expressed in public to justify official statements on the origins of the virus and on lockdown, mask, and vaccine policies, their private contemporaneous conversations confirm that even the top scientists were making decisions based on scientific uncertainty.
    Consequently, one of the key legacies of the public-private gap is growing distrust of official claims. That scepticism should extend to the future pandemic agenda. We rely on the World Health Organisation to coordinate among countries to prevent scourges such as pandemics reaching our shores, or at least mitigate their effects. In doing so, we must defer to an army of international bureaucrats who work in such institutions. A deference that relies on trust.
    Their salaries and careers depend on convincing us to part with more of our money to support their work. Yet, according to a new article on international pandemic financing in the Cambridge journal Health Economics, Policy and Law, the WHO and World Bank rely on dubious assumptions to calculate the return on investment case on which all major international efforts to mitigate future pandemics rely.
    This should alarm governments. Mitigation is worth investing in, as pandemics will occur from time to time. But the article shows that current investments will have an overall detrimental effect on global health. Most starkly, it suggests a deep rot in the quality of institutions we rely on as stewards of this commonly accepted global good.
    The WHO and World Bank report, produced at the request of the G20 in 2022, proposes an annual $31.1 billion budget for pandemic preparedness and prevention, about $10.5 billion of which would come through foreign aid (including Australia). About $26 billion would come from low and middle-income countries already struggling with economic issues including burgeoning Covid debt. For context, the entire WHO budget for 2024-25 was just $3.8 billion a year.
    The point of the WHO and World Bank's argument is that if we spend such resources on preparing for pandemics, we will reap orders of magnitude greater return on investment down the road, more than a thousandfold in some wealthy countries – a bargain difficult to refuse if true.
    The article from Leeds University shows that the financial arguments are based on smoke and mirrors. They rely on assumptions on the quality-adjusted life years lost to pandemics as against the big three global infectious diseases of HIV-AIDS, tuberculosis, and malaria; on the share of global funds to be devoted to pandemics in comparison to the other three per life saved in each case; and on the benefits to be gained from investments in vaccines and other pharmaceutical products instead of in the more basic determinants of health resilience in the population such as nutrition, sanitation, water, and hygiene. These are the factors, along with antibiotics and gains in medical advances, that have reduced the mortality toll from pandemics since the Spanish flu of 1918.
    Furthermore, the WHO and World Bank also discount the adjustments made to human behaviour to mitigate health risks as they become obvious, collateral costs of the pandemic response measures, and the likely benefits of investing in those measures.
    This matters because our government has signed on to the amended International Health Regulations, is expecting to sign the proposed WHO Pandemic Agreement, and looks set to sign a UN political agreement this September advocating for yet more money for the authors and beneficiaries of the growing pandemic industry. They are promising a lot of mo...
    6 min
  • Was My Paper on Flu Vaccine Studies a "Hot Potato" for Editors?
    By Eyal Shahar at Brownstone dot org.
    I think the answer is "yes," but here is the story for you to judge.
    Each year the CDC publishes estimates of the effectiveness of the flu vaccine in the previous season. Reported by several networks, these estimates are based on a research design that is called a test-negative case-control study.
    Over the years, the various authors have shared a similar analytical strategy: Early respiratory events were considered differently from later respiratory events (on the assumption that no effect is expected until immunity is built up). "Early" has typically been within two weeks post-vaccination.
    Several months ago, I realized that this special handling of early events is a source of bias called "immortal time." To expose the bias, I used causal diagrams, formally called "directed acyclic graphs (DAGs)." DAGs were introduced in landmark publications from the 1990s and are widely recognized in epidemiology as a methodological tool.
    I wrote a short paper with a scary title: "Immortal time bias in test-negative studies of the flu vaccine." I illustrated the bias by two simple DAGs that encoded the analytical approaches as described in those CDC-associated studies. The paper may be summarized in three bullet points:
    Immortal time is an overlooked bias in test-negative, case-control studies of the flu vaccine.
    The causal structure corresponds to misclassification bias or selection bias, depending on how early events were handled.
    The bias can be avoided by considering all events and estimating built-up vaccine effectiveness by consecutive post-vaccination days.
    I submitted the paper sequentially to three respected epidemiology journals. Surprisingly, the editor-in-chief of each journal rejected the paper within one week using boilerplate text. It was not sent for peer review. Why?
    There are three possible reasons:
    1. The message was not sufficiently important.
    2. The paper was poorly written.
    3. Soliciting peer review was not needed. The editor decided that the bias did not exist.
    I can quickly eliminate the first reason. Exposing entrenched bias in studies of the annual flu vaccine is of utmost importance. I didn't need to compete with any "more important" papers.
    Was it poorly written? I have published many scientific papers and two books. I am not a newcomer to epidemiology and even served as an associate editor for one of the three journals. So, that was not the reason.
    We are left with the third reason. Three editors (possibly more in-house) decided that my analysis was obviously wrong. They did not need any external peer review. Was that the case indeed? How likely is it that three editors have reached a unanimous, independent verdict on my analysis without soliciting peer reviews?
    I could have written a whole page on my expertise in the domains of causal diagrams and biases, but here is a short version of my record. I suggested a new taxonomy of biases based on DAGs and identified new types of bias. I authored about 20 DAG-related publications, including a book chapter. (Some of my articles were cited in the paper.) For sure, my methodological analysis was not "obviously wrong." More likely, it was obviously correct.
    So, why was my paper rejected without peer review? May I speculate?
    This paper has a startling message that discredits the CDC. All those studies about the effectiveness of the annual flu vaccine contained a mistaken analytical decision. The reported estimates are biased. Had my paper been published, it might have been picked up by some reporters. You can imagine the headlines.
    The editors were dealing with a hot potato. They did not want to take the risk that peer-reviewers would endorse the paper, which would force them to publish it. An upfront rejection was a safe way out.
    I tried once more. In my fourth submission to an epidemiology journal, I included the following cover letter:
    "Dear Editor,
    This short paper addresses immortal time in test-negative studies of the flu vac...
    7 min
  • Rethinking Polio Abstract Background Traditional Polio Etiology Additional Polio Etiologies Limitations of the Traditional Polio Pathogenesis Model The Gradient Paradox Questioning Paralytic Polio via Viremia Crossing the Blood-Brain Barrier Multiple Viru
    By Forrest Maready at Brownstone dot org.
    The prevailing understanding of poliovirus pathogenesis posits that the virus, following intestinal infection, gains access to the central nervous system (CNS) through viremia and subsequent crossing of the blood-brain barrier (BBB). However, this model fails to adequately explain several key epidemiological and clinical features of the historical polio epidemic, including the localized nature of paralysis, the disproportionate involvement of the lower limbs, the increased susceptibility of young children, and the striking predilection for anterior (motor) neuronal damage while simultaneously sparing posterior (sensory) spinal cord structures.
    We propose an alternative, multi-hit hypothesis in which environmental factors, particularly exposure to neurotoxic pesticides such as lead arsenate and DDT—coupled with anatomical factors, such as the proximity of spinal cord and intestines in children—play a critical role in increasing susceptibility to paralytic polio. In this model, pesticide-induced disruption of the intestinal barrier allows poliovirus to enter the intestinal lymphatic system, bypassing the need for systemic dissemination and BBB crossing.
    The virus is then transported through lymphatic vessels to areas near the spinal cord, where it can directly infect motor neurons or undergo retrograde axonal transport from nerve endings. This localized access, coupled with potential pesticide-induced neurotoxicity, viral replication, and immune dysregulation, may contribute to the development of paralytic disease, selectively targeting anterior horn motor neurons near the base of the spinal cord.
    The data presented in this overview indicates the need for research that considers multi-causal factors when it comes to understanding the history and effects of this illness. We propose that it is of the utmost importance to explore the role of environmental toxins in the development of paralysis, and to consider alternative avenues for intervention and prevention beyond poliovirus eradication alone.
    Poliomyelitis, more commonly known as polio, is an enteroviral infection caused by the poliovirus which sometimes causes inflammation within the grey matter of the spinal cord, a condition which can lead to muscle weakness, paralysis, and in extreme cases, death. Without proper muscle function, the limbs of affected patients can wither and become deformed, leading to severe handicap. If paralysis reaches the muscles that control respiration, unassisted breathing becomes difficult, if not impossible.
    Most commonly occurring in children, the condition appears in medical literature throughout history, albeit sporadically. In the late 1800s, polio began appearing in what was called "epidemic form." Rather than isolated cases, numerous groups of children began exhibiting signs of polio—the first formal documentation of which is said to have occurred in Rutland, Vermont in 1894, although that outbreak was preceded by a smaller, lesser-known cluster of 26 cases in Boston in 1893. Over the next few decades, epidemic polio spread around the country, initially constrained to rural areas but eventually making its way into urban locations—the 1916 outbreak in New York City considered the most dramatic.
    Epidemic polio experienced a second wave shortly after World War Two, a dramatic event culminating with the successful introduction of the inactivated Salk polio vaccine in 1955 and the attenuated Sabin polio vaccine in 1961. By the late 1950s, the paralysis of polio seemed to be on the wane. The number of children affected began to decline and parents slowly began to lose their fear of summertime swimming in pools and watering holes—a common activity associated with the onset of the dreaded disease.
    The causative agent in polio is the poliovirus, a small, single-stranded RNA virus belonging to the Enterovirus genus of the Picornaviridae family. There are three serotypes of poliovirus: type 1 (PV1), type 2 (...
    1 hr 20 min
  • David Morens and the Problem of Obedience
    By Rev. John F. Naugle at Brownstone dot org.
    Recently the Church celebrated the feast of St. Maximillan Kolbe, a conventual Franciscan who was held as a political prisoner at Auschwitz by the Nazis until he offered his own life in exchange for that of a husband and father.
    For his feast, those who celebrated the Church's Liturgy of the Hours read an excerpt from one of his letters. In this letter he treats the subject of obedience:
    God, who is all-knowing and all-wise, knows best what we should do to increase his glory. Through his representatives on earth he continually reveals his will to us; thus it is obedience and obedience alone that is the sure sign to us of the divine will. A superior may, it is true, make a mistake; but it is impossible for us to be mistaken in obeying a superior's command. The only exception to this rule is the case of a superior commanding something that in even the slightest way would contravene God's law. Such a superior would not be conveying God's will.
    For contemporary men of either modern or postmodern liberalism, this understanding of obedience is almost inconceivable. Having bought into the idea of radical individualism, the turning over of one's will to a superior is dismissed as somehow against the dignity of the person.
    Note, however, how carefully the ecclesiastical counsel of obedience is circumscribed within the context of religion. Obedience is given only voluntarily through an act of the will. It is always restrained by God's law; the obligation to obey never violates faith or morals. Finally, it is understood that such obedience is simply a higher level of freedom, freedom from the selfish desire of money, power, or pleasure. Such obedience is ordered to perfection of character.
    This stands in contrast to the type of obedience we see demanded in a criminal organization such as the mob. Obedience is procured through force or fear. It is proven precisely through the commission of crimes against man's law and God's law. It leads to abject slavery to one's superiors, with the payoff being access to money, power, and pleasure. Such a structure of obedience is a diabolical counterfeit of the real thing.
    This contrast came to mind as David Morens, a former top NIAID senior advisor to Anthony Fauci, pleaded guilty to conspiracy to defraud by destroying federal records. This was a man who lived under a regime of ruthless obedience. He knew that what he was doing was wrong, but he owed fealty to his co-conspirators. Even worse, the reward for his "behind-the-scenes shenanigans" was merely two bottles of wine. It is both sad and ironic that the wine was "The Prisoner."
    17/ One last detail.
    The wine that sealed the arrangement — two bottles, with a card thanking Morens for his "behind-the-scenes shenanigans" — was named The Prisoner. Its label: Goya's etching of a shackled man.
    Sentencing: November 12. I'll be covering every filing.
    Follow… pic.twitter.com/MfqY7zJRSt— Sayer Ji (@sayerjigmi) August 18, 2026
    It appears that, in an era which rejects religious obedience as a useless medieval artifact, we are left only with the dark counterfeit of it in our halls of government.
    Consider the iron grip Nancy Pelosi had and Hakeem Jeffries now has over Democrats in the House; any abbot would be envious of such perfect compliance. Consider how, despite popular sentiment against war, Congress refuses to assert any responsibility for our ongoing military quagmire.
    Consider how governors in 2020 were clearly taking orders from unnamed people to implement lockdowns and masking. Finally, consider how countless individuals in the administrative state obviously work for the pharmaceutical industry and not the taxpayers who pay their salary.
    Our system of government seems to be overrun by men and women who have destroyed any semblance of human freedom in their hearts in order to obtain and protect their jobs. Little by little their obedience is procured from those malignant actors whom they serve by demandi...
    6 min
  • What Would a Brutally Honest Man Look Like? Drugs for Covid-19 Chloroquine and Hydroxychloroquine Ivermectin and Itajaí The rhetorical trick The Spirit of the Times Imagining a brutally honest man It's impossible to be honest
    By Filipe Rafaeli at Brownstone dot org.
    Diogenes was one of the most iconic philosophers of ancient Greece. He roamed the streets of Athens in broad daylight carrying a lit lantern. When asked why he was performing such an unusual scene, Diogenes would reply that he was looking for an honest man. He never found one.
    More than two thousand years later, Diogenes' questioning remains just as valid and relevant as much of the teachings of the ancient Greek philosophers. Recently, I was reminded of him when I came across an analysis by a columnist in one of Brazil's largest newspapers. This analysis, which addresses the effectiveness of ivermectin during the pandemic, resurfaced when the pandemic returned to the headlines following the revelations from Anthony Fauci's diary—the czar of the US government's Covid-19 response.
    In fact, given the accumulation of evidence since the very beginning of the Covid-19 drama, along with the facts that have been laid out and the proven lies that have slowly come to light, I began to wonder what a truly honest person would say today about this period in history. In this article, I propose to carry out this exercise. But first, let's delve a little into the context.
    In theory, I wouldn't even need to introduce the subject much. Any human being who lived through the pandemic and at least skimmed the news knows that the proposals for hydroxychloroquine and ivermectin against Covid came to nothing. They started out as scientific possibilities, as hopes. But they were quickly dismissed by the authorities. After that, those who talked about the subject were treated as "conspiracy theorists." Those who continued to insist later became the subject of studies on health disinformation or political extremism.
    The situation was so serious that even doctors—even after regulatory agencies like the WHO strongly recommended against it—continued prescribing it for Covid-19 to their patients. Some were fined, others lost their licenses to practice medicine. At this point, after everything had been so thoroughly clarified, the subject shifted to a different level: it ceased to be science and became fodder for comedians.
    When a subject becomes fodder for comedians, that is the pinnacle of a society's consolidated knowledge. It means you can no longer have a serious conversation with the few stragglers still repeating such nonsense. All that's left to do is make jokes. One example is the Brazilian comedian and influencer Maria Bopp, who has over 1 million followers on Instagram. She produced a samba. The lyrics talk about people who deny science, such as those who believe the Earth is flat. This is just one example among several comedy sketches, political cartoons, and jokes.
    The same thing happened in the US. Forbes ran a story about those who used humor to combat the disinformation surrounding ivermectin as a solution for Covid-19. Television comedians took aim at both medications. The overall tone was one of mockery.
    Before I talk about the text by columnist Frankito (Franklin Weise), who defines himself as a data analyst, in the newspaper O Estado de S. Paulo, where he addresses ivermectin, let me talk a bit about chloroquine and its slightly younger, yet septuagenarian, sister, hydroxychloroquine.
    We are in 2026. Today, we open the University of Oxford website. On the site, we find a published news piece: "Hydroxychloroquine provides moderate COVID-19 prevention, large clinical trial shows." In other words, the subject was the butt of jokes, synonymous with crazy people across all media, yet it is reported as effective on the website of the university that, in any serious ranking, is placed among the first, second, or third in teaching quality and scientific output. Oxford, depending on the year, rivals Harvard and MIT in the rankings.
    I wanted to go straight to Frankito's text, or already carry out the exercise of the "brutally honest man" with you, the reader, but I need to explain a little about this new...
    22 min

About Brownstone Journal

From the publisher's feed

Daily readings from Brownstone Institute authors, contributors, and researchers on public health, philosophy, science, and economics.

More shows like Brownstone Journal

Peak Prosperity by Chris Martenson

Peak Prosperity

571 Listeners

Wise Traditions by Weston A. Price Foundation

Wise Traditions

2,384 Listeners

Gold Goats 'n Guns Podcast by Tom Luongo

Gold Goats 'n Guns Podcast

326 Listeners

Coffee and a Mike by Michael Farris

Coffee and a Mike

422 Listeners

The Delingpod: The James Delingpole Podcast by James Delingpole

The Delingpod: The James Delingpole Podcast

453 Listeners

American Thought Leaders by The Epoch Times

American Thought Leaders

1,252 Listeners

DarkHorse Podcast by Bret Weinstein & Heather Heying

DarkHorse Podcast

5,430 Listeners

The Sharyl Attkisson Podcast by Sharyl Attkisson

The Sharyl Attkisson Podcast

1,804 Listeners

Bannon`s War Room by WarRoom.org

Bannon`s War Room

16,569 Listeners

THE MCCULLOUGH REPORT by Dr. Peter McCullough

THE MCCULLOUGH REPORT

2,436 Listeners

Facts Matter by The Epoch Times

Facts Matter

1,267 Listeners

Man in America Podcast by Man in America

Man in America Podcast

598 Listeners

Doc Malik by Ahmad Malik

Doc Malik

121 Listeners

The Tucker Carlson Show by Tucker Carlson Network

The Tucker Carlson Show

17,911 Listeners

Victor Davis Hanson: In His Own Words by Victor Davis Hanson | The Daily Signal

Victor Davis Hanson: In His Own Words

1,846 Listeners